My Sponsor

Open Directory Project at dmoz.org < Traffic Exchange with 160,000+ members banner ads

My Sponsor

Saturday, December 12, 2009

0comments

White Willow


White Willow: Encyclopedia - White Willow


White Willow

* See Golden Willow for information on the horse of that name.


The White Willow is a willow native to Europe, and western and central Asia. It is a large deciduous tree up to 20-30 m tall. The name derives from the leaves, which are paler than most other willows, due to a covering of very fine silky white hairs, particularly on the underside. The leaves are typically 5-10 cm long and 1-1.5 cm wide. The shoots in the typical species are grey-brown to green-brown. The flowers are catkins, produced in early spring.

A number of cultivars and hybrids of White Willow have been selected for forestry and horticulture use:

* The Cricket-bat Willow (Salix alba 'Caerulea') is grown as a specialist timber crop in Britain, mainly for the production of cricket bats, but also for other uses where a tough, lightweight wood that does not splinter easily, is required. It is distinguished mainly by its growth form, very fast growing with a single straight stem, and also by its slightly larger leaves (10-11 cm long, 1.5-2 cm wide) with a more blue-green colour. Its origin is unknown, but it may be a hybrid between White Willow and Crack Willow (Salix fragilis).
* The Weeping Willow (Salix × sepulcralis 'Chrysocoma', syn. Salix 'Tristis') is a hybrid between White Willow and Peking Willow (Salix babylonica, syn. Salix matsudana).
* The Golden Willow (Salix alba 'Vitellina') is a cultivar grown in gardens for its shoots, which are golden yellow for 1-2 years before turning brown. It is particularly decorative in winter; the best effect is achieved by coppicing it every 2-3 years to stimulate the production of longer young shoots with better colour. Two other similar cultivars, 'Britzensis' and 'Cardinal', have orange-red shoots.

White Willows are fast-growing, but short-lived, being susceptible to several diseases, including watermark disease caused by the bacterium Erwinia salicis (named because of the characteristic 'watermark' staining in the wood) and willow anthracnose, caused by the fungus Marssonina salicicola. These diseases can be a serious problem on trees grown for timber or ornament.

White Willow - Medicinal Uses

Hippocrates, a Greek physician for whom the Hippocratic Oath is named, wrote in the 5th century BC about a bitter powder extracted from willow bark that could ease aches and pains and reduce fevers. This remedy is also mentioned in texts from ancient Sumeria, Egypt and Assyria. Native American Indians used it for headaches, fever, sore muscles, rheumatism, and chills. The Reverend Edward Stone, a vicar from Chipping Norton in Oxfordshire England, noted in 1763 that the bark of the willow was effective in reducing a fever.

The active extract of the bark, called salicin, after the Latin name for the White willow (Salix alba), was isolated to its crystaline form in 1828 by Henri Leroux, a French pharmacist, and Raffaele Piria, an Italian chemist, who then succeeded in separating out the acid in its pure state. Salicin is highly acidic when in a saturated solution with water (pH = 2.4), and is called salicylic acid for that reason. This is the precursor to modern aspirin (acetylsalicylic acid).

White Willow illustration

Catkins

Category: Salicaceae


0comments

Understanding Pine Bark Extract


Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Research Study / Stanford
Antioxidant Natural Supplement Study
Principal Investigator: Randall S. Stafford
Funding Agency: Toyo Shinyaku Co., Ltd.
Duration: 10/1/2006 - 08/31/2009

The UPBEAT study is a randomized, placebo-controlled, double-blind, parallel trial that will investigate the efficacy and safety of Flavangenol® (Toyo Shinyaku, Japan)*, a pine bark extract. We are currently recruiting for this study. We will randomize a total of 130 individuals to take 200 mg of Flavangenol or a placebo once per day for 12 weeks. These participants will be individuals at mildly or moderately elevated risk of cardiovascular disease (CVD) because of having prehypertension and excess body weight. Results from this trial will contribute to the growing evidence that is much needed for millions of current and future consumers of pine bark extracts and other OPC products as well as for health care professionals.

Pine bark has been used as a foodstuff for thousands of years in human history. Today, pine bark extracts and other OPCs products (especially grape seed extracts) are widely consumed as a food ingredient or dietary supplement. Extensive research conducted with several formulations of pine bark extracts has established its safety and tolerability for human consumption. More recent research has focused primarily on clinical efficacy and growing data suggest an array of cardiovascular benefits. However, the studies published to date on the clinical efficacy of pine bark extracts all have outstanding methodological limitations, for example, lack of a control group, lack of randomization, lack of or inadequate blinding, insufficient statistical power, and incorrect statistical analyses.

0comments

Pine Bark for Osteoarthritis Pain Relief


Pine Bark for Osteoarthritis Pain Relief

A new study on pine bark as an osteoarthritis treatment, published in the Journal of Phytotherapy Research, shows Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, reduced osteoarthritis symptoms by 56 percent and provided osteoarthritis pain relief.

In the randomized, double-blind, placebo-controlled study, held at Italy's Chieti-Pescara University, 156 patients with knee osteoarthritis received 100 milligrams of Pycnogenol or placebo daily for three months and were then evaluated using a number of tools. Patients were permitted to continue taking their choice of pain medication provided they recorded every tablet in a diary for later evaluation.

Results indicated pine bark was an effective osteoarthritis treatment and provided osteoarthritis pain relief. In addition to the statistic cited above, the Pycnogenol group also:

* Experienced a 55 percent improvement in joint pain.

* Reduced pain medication use by 58 percent.

* Had a 63 percent improvement in gastrointestinal complications.

* Reduced stiffness by 53 percent.

* Improved physical function scores by 57 percent.

* Enhanced overall well being by 64 percent.

"The results of this study are significant as they clearly demonstrate the clinical action of Pycnogenol on OA and management of symptoms,” says Gianni Belcaro, MD, PhD, a lead researcher of the study. “The use of Pycnogenol may reduce costs and side effects of anti-inflammatory agents and offer a natural alternative solution to people suffering from OA."

 

c o n t r a c e p t i v e Blak Magik is Designed by productive dreams for smashing magazine Bloggerized by Ipiet © 2009